An American physician's assistant has been flown from West Africa to the United States for treatment of Lassa fever, according to recent reports from CNN and Emory University Hospital.
Some topics: weighing risks and benefits, ethical issues, and global involvement.
Canada can now be added to the growing list of countries that have detected MCR-1, the recently identified worrisome gene that disables the last-line antibiotic colistin, after it was detected in a patient and in ground beef sold in 2010, the Toronto Star reported today.
After being identified for the first time in China in November, the gene has now been confirmed in samples from at least 11 countries.
The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.
In its annual report, TFAH said there are still major gaps and funding needed to battle new threats.
The analysis is a key part of a federal review of controversial studies on H5N1 and other pathogens.
The US Centers for Disease Control and Prevention (CDC) has replaced its longtime head of national lab regulation after a series of key lab safety breaches involving bioterror pathogens like Bacillus anthracis—which causes anthrax—and H5N1 avian flu viruses, USA Today reported yesterday.
The US Government Accountability Office (GAO) today recommended in a report that the Department of Homeland Security's (DHS's) BioWatch program not pursue any upgrades to its second-generation (Gen-2) technology for monitoring the country for potential bioterror attacks until it can provide better efficacy data.
Recommendations include executive-level management that spells out a national plan, pulls together a policy council, and unifies the biodefense budget.
The NSABB plans to release final recommendations in spring 2016.